Inclusion in neurological research: empowering people living with neurological diseases
- 7 January 2025
- journal article
- research article
- Published by Springer Nature in Nature Reviews Neurology
- Vol. 21 (3) , 159-170
Abstract
The value of involving people living with diseases in the research process is increasingly recognized by professional associations and regulatory agencies alike. Patient contributions range from disease prevention and diagnosis to medication planning, and from advocacy to guideline production and clinical trial design. Thanks to the efforts of activists and advocates, new models of patient inclusion in medical research are being developed to replace outdated non-participative and tokenistic paradigms. New modalities of patient participation in research — for example, the introduction of patient experts, who work closely with researchers and clinicians — have progressively empowered individuals who are living with diseases. In this Perspective, we provide an overview of the current status of patient involvement in medical research, with a specific focus on neurology. We also discuss the existing and future roles of patient experts in neurological research.Keywords
This publication has 59 references indexed in Scilit:
- Developing clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interestImplementation Science, 2012
- Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithmNature Biotechnology, 2011
- The power of social networking in medicineNature Biotechnology, 2009
- The history and challenge of HIV preventionThe Lancet, 2008
- Introduction: Patient organization movements and new metamorphoses in patienthoodSocial Science & Medicine, 2006
- Expert patients usher in a new era of opportunity for the NHSBMJ, 2003
- Stroke preventionNeurology, 2000
- MRC quality of life studies using a daily diary card—practical lessons learned from cancer trialsQuality of Life Research, 1995
- Tacrine for Alzheimer's DiseaseJAMA, 1994
- AIDS, Activism, and the Politics of HealthNew England Journal of Medicine, 1992